A Multicenter Single-arm Prospective Clinical Study on First-line Treatment of Pancreatic Cancer Liver Metastases With Arterial Infusion Chemotherapy and Embolization Combined With Dual Immune Checkpoint Inhibitors.

To evaluate the efficacy of arterial infusion chemotherapy and embolization combined with iparplidutol-volerilis (QL1706) as first-line treatment for pancreatic cancer liver metastases based on progression-free survival (PFS).

NCT Number	NCT07333287
Lead Sponsor	Shandong Provincial Hospital
Conditions	Pancreatic Cancer Liver Metastases, Immunotherapy-naive
Enrollment	38 participants
Start Date	2026-02-01
Primary Completion	2027-02-28 (estimated)
Study Completion	2028-11-30 (estimated)
Updated on ClinicalTrials.gov	2026-01-12